TrialAnnals of hematology2013

Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study.

Ali T Taher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.